Rayno Dx And Tools: Abbott Buys Alere For $5.8B Expanding Point-Of-Care Diagnostics Platforms

The acquisition is expected to be accretive to 2016 earnings and will boost EPS by 12-13 cents with tax savings of $500M by 2019. Following the deal Abbot Labs’ sales in the clinical diagnostics sector would exceed $7B.